The Company expects to receive aggregate gross proceeds of US$8 million from the Offering, before deducting underwriting discounts and other related expenses. The Offering is expected to close on or ...
By targeting surface markers on cancer cells, engineered synthetic receptors expressed on immune cells can be directed to ...
Flow-Launcher/Flow.Launcher.Plugin.Sys’s past year of commit activity ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback